193 related articles for article (PubMed ID: 31378897)
1. LncRNA SNHG1 promotes cell proliferation in laryngeal cancer via Notch1 signaling pathway.
Liu T; Zuo JJ; Li F; Xu YC; Zheng AY; Tao ZZ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6562-6569. PubMed ID: 31378897
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of SNHG1 suppresses cell proliferation and invasion by regulating Notch signaling pathway in esophageal squamous cell cancer.
Zhang Y; Jin X; Wang Z; Zhang X; Liu S; Liu G
Cancer Biomark; 2017 Dec; 21(1):89-96. PubMed ID: 29081407
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of long non-coding RNA SNHG1 contributes to proliferation and metastasis in laryngeal squamous cell carcinoma.
Lin SX; Jiang H; Xiang GZ; Zhang WR; Weng YH; Qiu FD; Wu J; Wang HG
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1333-1341. PubMed ID: 29565491
[TBL] [Abstract][Full Text] [Related]
4. lncRNA SNHG1 suppresses gastric cancer cell proliferation and promotes apoptosis via Notch1 pathway.
Zhang Z; Wang H
J BUON; 2020; 25(1):302-307. PubMed ID: 32277646
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of long noncoding RNA SNHG1 inhibits cell proliferation, metastasis, and invasion by suppressing the Notch-1 signaling pathway in pancreatic cancer.
Cui L; Dong Y; Wang X; Zhao X; Kong C; Liu Y; Jiang X; Zhang X
J Cell Biochem; 2019 Apr; 120(4):6106-6112. PubMed ID: 30520072
[TBL] [Abstract][Full Text] [Related]
6. LncRNA SNHG1 promotes liver cancer development through inhibiting p53 expression via binding to DNMT1.
Li SJ; Wang L; Sun ZX; Sun SJ; Gao J; Ma RL
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2768-2776. PubMed ID: 31002127
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
Li Y; Xu J; Guo YN; Yang BB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
[TBL] [Abstract][Full Text] [Related]
8. LncRNA SNHG1 promotes EMT process in gastric cancer cells through regulation of the miR-15b/DCLK1/Notch1 axis.
Liu ZQ; He WF; Wu YJ; Zhao SL; Wang L; Ouyang YY; Tang SY
BMC Gastroenterol; 2020 May; 20(1):156. PubMed ID: 32423385
[TBL] [Abstract][Full Text] [Related]
9. Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):329-335. PubMed ID: 29424921
[TBL] [Abstract][Full Text] [Related]
10. LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g/TFRC.
Cui P; Dai X; Liu R; Cao H
J Biochem Mol Toxicol; 2021 Oct; 35(10):e22878. PubMed ID: 34472153
[TBL] [Abstract][Full Text] [Related]
11. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA GClnc1 promotes progression of colorectal cancer by inhibiting p53 signaling pathway.
Dong YX; Pang ZG; Zhang JC; Hu JQ; Wang LY
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5705-5713. PubMed ID: 31298323
[TBL] [Abstract][Full Text] [Related]
13. Upregulation of the long non-coding RNA SNHG1 predicts poor prognosis, promotes cell proliferation and invasion, and reduces apoptosis in glioma.
Wang Q; Li Q; Zhou P; Deng D; Xue L; Shao N; Peng Y; Zhi F
Biomed Pharmacother; 2017 Jul; 91():906-911. PubMed ID: 28501778
[TBL] [Abstract][Full Text] [Related]
14. LncRNA BC200 regulates the cell proliferation and cisplatin resistance in non-small cell lung cancer via PI3K/AKT pathway.
Gao BB; Wang SX
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):1093-1101. PubMed ID: 30779077
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA NALT1-induced gastric cancer invasion and metastasis
Piao HY; Guo S; Wang Y; Zhang J
World J Gastroenterol; 2019 Nov; 25(44):6508-6526. PubMed ID: 31802831
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA LINP1 promotes the malignant progression of prostate cancer by regulating p53.
Wu HF; Ren LG; Xiao JQ; Zhang Y; Mao XW; Zhou LF
Eur Rev Med Pharmacol Sci; 2018 Jul; 22(14):4467-4476. PubMed ID: 30058678
[TBL] [Abstract][Full Text] [Related]
17. LncRNA SNHG1 promotes tumor progression and cisplatin resistance through epigenetically silencing miR-381 in breast cancer.
Zhang M; Yang L; Hou L; Tang X
Bioengineered; 2021 Dec; 12(2):9239-9250. PubMed ID: 34806925
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG1 overexpression regulates the proliferation of acute myeloid leukemia cells through miR-488-5p/NUP205 axis.
Bao XL; Zhang L; Song WP
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5896-5903. PubMed ID: 31298340
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MSTO2P promotes proliferation and autophagy of lung cancer cells by up-regulating EZH2 expression.
Wang LJ; Sun GZ; Chen YF
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3375-3382. PubMed ID: 31081092
[TBL] [Abstract][Full Text] [Related]
20. LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling.
Guo Q; Qian Z; Yan D; Li L; Huang L
Biomed Pharmacother; 2016 Aug; 82():589-94. PubMed ID: 27470401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
